A Regulatory Standoff with High Stakes In a move that sent shockwaves through the biotechnology sector, the U.S. Food and Drug Administration (FDA) has taken the extraordinary step of refusing to conduct a formal review of Moderna's biologics license application for its mRNA-based influenza
A Federal Reckoning: Targeting the Middlemen of Medicine The persistent and escalating cost of prescription drugs in the United States has ignited widespread public frustration and become a recurring battleground in political debate. A proposed rule from the Department of Labor (DOL) is now taking
Patient Safety in Question Unpacking the Integra Wound Care Recall When a medical device intended to heal instead causes harm, it strikes at the core of patient trust, demanding an immediate and thorough investigation into what went wrong. Medical device company Integra LifeSciences has initiated a
The intricate web connecting pharmaceutical manufacturers to patient medicine cabinets is quietly being rewoven as a landmark settlement threatens to expose the secretive financial mechanics driving America's insulin crisis. For years, the rising cost of this life-saving medication has been a
The year 2026 presents a formidable challenge for healthcare cybersecurity, where the very technology promising to revolutionize patient care also threatens to become its greatest vulnerability. Artificial intelligence is no longer a futuristic concept but a present-day reality, forcing a critical
The digitization of sensitive patient information has inadvertently rolled out a welcome mat for cybercriminals, transforming the healthcare sector into a premier target for sophisticated digital assaults. An extensive analysis of incidents from 2023 paints a grim picture of a system under siege,
